Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapy

Immune checkpoint inhibitors (ICIs) may cause immune-related adverse events (IRAEs). Characterisation and data on treatment of musculoskeletal IRAEs are scarce. In this cohort study, patients receiving ICI therapy who experienced arthralgia were evaluated for the presence of synovitis. Data on demog...

Descripción completa

Detalles Bibliográficos
Autores principales: Leipe, Jan, Christ, Lisa A, Arnoldi, Andreas P, Mille, Erik, Berger, Frank, Heppt, Markus, Goldscheider, Ilana, Kauffmann-Guerrero, Diego, Huber, Rudolf M, Dechant, Claudia, Berking, Carola, Schulze-Koops, Hendrik, Skapenko, Alla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Autoimmunity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109812/
https://www.ncbi.nlm.nih.gov/pubmed/30167328
http://dx.doi.org/10.1136/rmdopen-2018-000714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109812/
https://www.ncbi.nlm.nih.gov/pubmed/30167328
http://dx.doi.org/10.1136/rmdopen-2018-000714

Ejemplares similares